XM does not provide services to residents of the United States of America.
G
G

Grifols

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Grifols Informs On Committee Of Board Of Directors

BRIEF-Grifols Informs On Committee Of Board Of Directors July 12 (Reuters) - Grifols GRLS.MC : IN RELATION TO POSSIBLE TRANSACTION WITH BROOKFIELD, TO SET UP COMMITTEE OF BOARD OF DIRECTORS COMPOSED EXCLUSIVELY OF INDEPENDENT DIRECTORS TO APPOINT AND HIRE LATHAM & WATKINS LLP AS LEGAL ADVISORS FOR NON-CONFLICTED DIRECTORS AND TRANSACTION COMMITTEE
G

French stocks drag European shares lower on political concerns

UPDATE 2-French stocks drag European shares lower on political concerns For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 down 0.9% Indivior declines on lower profit forecast BP slides after Q2 warning erases stock's gains in 2024 Dassault Systemes falls after guidance cut Updated at 1615 GMT By Shubham Batra and Shristi Achar A July 9 (Reuters) - European shares dropped for a third straight session on Tuesday, dragged down by we
D
G
E
F
U
G

Busy beginning in Britain

LIVE MARKETS-Busy beginning in Britain Stoxx 600 down 0.2%, U.S. futures up around 0.2% CAC 40 0.6% lower election still in focus Indivior down 38%, Stoxx 600 biggest faller Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com BUSY BEGINNING IN BRITAIN European shares are a touch lower in the first hour of trading, but the news flow is at the single-stock rather than index level.
A
E
G
P
R
R
E
F
U
G

Profit warnings and take-privates

LIVE MARKETS-Profit warnings and take-privates Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com PROFIT WARNINGS AND TAKE PRIVATES For the first time in a few days, there is no major political news for European stocks to digest. The big picture story is back to being about the U.S.
E
G
P
R
E
F
G

Grifols says founding family, Brookfield looking to delist drugmaker

RPT-UPDATE 3-Grifols says founding family, Brookfield looking to delist drugmaker Repeats story first published on Monday By Andres Gonzalez, David Latona, Joan Faus LONDON/MADRID/BARCELONA, July 8 (Reuters) - The Grifols family and Canadian fund Brookfield BN.TO have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols GRLS.MC with the intent to delist it, the companies said in regulatory filings on Monday.
G
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.